APA (7th ed.) Citation

JH, C., CW, C., YY, C., CH, Y., WB, Y., YC, H., . . . CJ, H. (2026). Chronic cerebral hypoperfusion exacerbates amyloid and tau pathology by impairing glymphatic transport via AQP4- and VEGF-mediated pathways: Insights from a vascular to mixed-type dementia model. Alzheimer's & dementia : the journal of the Alzheimer's Association, 22(3), e71290. https://doi.org/10.1002/alz.71290

Chicago Style (17th ed.) Citation

JH, Chen, Chang CW, Chen YY, Yang CH, Yang WB, Hsieh YC, Liang YW, Li SJ, and Hu CJ. "Chronic Cerebral Hypoperfusion Exacerbates Amyloid and Tau Pathology by Impairing Glymphatic Transport via AQP4- and VEGF-mediated Pathways: Insights from a Vascular to Mixed-type Dementia Model." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 22, no. 3 (2026): e71290. https://doi.org/10.1002/alz.71290.

MLA (9th ed.) Citation

JH, Chen, et al. "Chronic Cerebral Hypoperfusion Exacerbates Amyloid and Tau Pathology by Impairing Glymphatic Transport via AQP4- and VEGF-mediated Pathways: Insights from a Vascular to Mixed-type Dementia Model." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 22, no. 3, 2026, p. e71290, https://doi.org/10.1002/alz.71290.